ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
99,00
0,00
(0,00%)
Geschlossen 02 Februar 10:00PM
Echtzeitdaten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
99,00
Gebot
98,50
Fragen
99,00
Volumen
5.748
98,50 Tagesbereich 101,00
56,74 52-Wochen-Bereich 102,00
Marktkapitalisierung
Handelsende
99,00
Handelsbeginn
99,00
Letzte Trade
6
@
99
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
3.853
Ausgegebene Aktien
1.473.827.485
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
96,09
Gewinn pro Aktie (EPS)
1,07
Erlöse
14,35B
Nettogewinn
1,57B

Über Boston Scientific Dl 01

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Boston Scientific Dl 01 is listed in the Surgical,med Instr,apparatus sector of the Tradegate (DE) with ticker BSX. The last closing price for Boston Scientific Dl 01 was 99,00 €. Over the last year, Boston Scientific Dl 01 shares have traded in a share price range of 56,74 € to 102,00 €.

Boston Scientific Dl 01 currently has 1.473.827.485 shares in issue. The market capitalisation of Boston Scientific Dl 01 is 145,91 € billion. Boston Scientific Dl 01 has a price to earnings ratio (PE ratio) of 96.09.

BSX Neueste Nachrichten

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and 2009 Financial Results

NATICK, Mass., Jan. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended...

Boston Scientific Announces Pricing of $2 Billion of Senior Notes

NATICK, Mass., Dec. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets NATICK, Mass. and LONDON, Nov. 20...

Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent

Complete portfolio of Company's WallFlex Stent family of self-expanding metal stents now available in U.S., Europe and other international markets NATICK, Mass. and LONDON, Nov. 20...

Boston Scientific Announces FDA Clearance and U.S. and European Availability of WallFlex(R) Biliary RX Covered Stents

Three models of stenting system now available for palliative treatment of malignant common bile duct strictures NATICK, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation...

Boston Scientific to Participate in Morgan Stanley Global Healthcare Conference

NATICK, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Conference, September 14-15. Ray...

Boston Scientific to Participate in Thomas Weisel Partners Health Care Conference

NATICK, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in the Thomas Weisel Partners 2009 Health Care Conference, September 9...

PreSCD II Registry Shows ICDs Lead to 44 Percent Reduction in Mortality for Heart Attack Survivors

NATICK, Mass. and BARCELONA, Sept. 1 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced long-term data from the Prevention of Sudden Cardiac Death II registry...

Video: MADIT-CRT Trial Results Provide Clinical Evidence That Cardiac Resynchronization Therapy Significantly Slows Heart Failur

Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC NATICK, Mass., and BARCELONA, Spain, Sept. 1 /PRNewswire/ -- Boston Scientific...

Boston Scientific Announces Schedule for European Society of Cardiology Congress

NATICK, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) today announced the schedule of the Company's major events and news announcements for the European...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.51.5384615384697.510295.5439398.83399344DE
411.513.142857142987.510287534693.33954243DE
121822.22222222228110280.5385389.70575163DE
263145.58823529416810258268684.72322075DE
5242.0273.745173745256.9810256.74182479.86074933DE
15660.85159.50196592438.1510233.4277673.17594353DE
26069.24232.66129032329.7610228.9360671.38348894DE

BSX - Frequently Asked Questions (FAQ)

What is the current Boston Scientific Dl 01 share price?
The current share price of Boston Scientific Dl 01 is 99,00 €
How many Boston Scientific Dl 01 shares are in issue?
Boston Scientific Dl 01 has 1.473.827.485 shares in issue
What is the market cap of Boston Scientific Dl 01?
The market capitalisation of Boston Scientific Dl 01 is EUR 145,91B
What is the 1 year trading range for Boston Scientific Dl 01 share price?
Boston Scientific Dl 01 has traded in the range of 56,74 € to 102,00 € during the past year
What is the PE ratio of Boston Scientific Dl 01?
The price to earnings ratio of Boston Scientific Dl 01 is 96,09
What is the cash to sales ratio of Boston Scientific Dl 01?
The cash to sales ratio of Boston Scientific Dl 01 is 10,51
What is the reporting currency for Boston Scientific Dl 01?
Boston Scientific Dl 01 reports financial results in USD
What is the latest annual turnover for Boston Scientific Dl 01?
The latest annual turnover of Boston Scientific Dl 01 is USD 14,35B
What is the latest annual profit for Boston Scientific Dl 01?
The latest annual profit of Boston Scientific Dl 01 is USD 1,57B
What is the registered address of Boston Scientific Dl 01?
The registered address for Boston Scientific Dl 01 is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Boston Scientific Dl 01 website address?
The website address for Boston Scientific Dl 01 is www.bostonscientific.com
Which industry sector does Boston Scientific Dl 01 operate in?
Boston Scientific Dl 01 operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
0T8BTCTM Kids IT Education Inc
0,845 €
(380,11%)
187,08k
3XUHuijing Holdings Co Ltd
0,003 €
(50,00%)
5,17k
E3O1Nexoptic Technology Corp
0,0225 €
(50,00%)
1,34k
9I0Pluto Ventures Inc
0,35 €
(49,57%)
17,2k
VOPInvestigator Resources Ltd
0,0195 €
(44,44%)
3,08k
WWTWater Ways Technologies Inc
0,002 €
(-50,00%)
48,77k
AWY0Percheron Therapeutics Ltd
0,003 €
(-45,45%)
1.000
45AAlchemy Resource Ltd
0,0025 €
(-37,50%)
95,16k
41KQuebec Rare Earth Elements Corp
0,021 €
(-34,38%)
63k
POTAPortofino Resources Inc
0,0038 €
(-32,14%)
15k
D7GNel ASA
0,2011 €
(0,05%)
3,39M
DMLSayona Mining Limited
0,015 €
(7,14%)
1,95M
3CPXiaomi Corporation
4,90 €
(-3,92%)
1,78M
RQ0DWave Quantum Inc
5,742 €
(5,82%)
1,35M
HPMHorizon Petroleum Ltd
0,15 €
(11,11%)
1,01M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock